Proof your treatment works, on one page.
CGRP coverage gets renewed when you can document that your migraine days dropped. This is the report that documents it, assembled automatically from the seconds you spend logging. It works for every major CGRP preventive, including Aimovig (erenumab), Ajovy (fremanezumab), Emgality (galcanezumab), Vyepti (eptinezumab), and oral gepants like Qulipta.
Prior-authorization renewal
CGRP treatment response
12-month preventive course
Baseline MMD
13.6
Current MMD
5.2
Reduction
−62%
01
The renewal
Your insurer re-evaluates CGRP coverage on a schedule and asks for proof it's helping.
02
The evidence
That proof is mostly numbers: migraine days down from baseline, fewer rescue meds, lower disability scores.
03
The gap
Most diaries leave you to reconstruct all of that by memory the night before your appointment.
Everything a reviewer looks for, and nothing they don't.
Each element maps to the questions on a typical prior-authorization renewal, so the conversation with your neurologist and insurer starts from evidence.
Baseline vs current MMD
Your pre-treatment baseline and current monthly migraine days, side by side, with the percentage reduction calculated automatically.
Breakthrough & overuse
Rescue-medication days per month with automatic medication-overuse (MOH) flags: the detail reviewers look for.
MIDAS & HIT-6 scores
Standardized disability scores tracked from baseline to current, in the language your neurologist and insurer already use.
Adherence & timeline
A clean treatment timeline and adherence summary that shows the preventive was used as prescribed.
Hand it over without handing over your privacy.
Encrypted care-team link
Generate a secure link, encrypted on your device and opened with a passcode you control. Share it for one appointment, then revoke it.
- Passcode-protected
- Revocable any time
- Encrypted before it leaves your phone
Clean PDF export
Prefer paper? Export a tidy, print-ready PDF to bring to your appointment or attach to a patient-portal message.
- Print-ready layout
- Everything on one page
- Yours to keep and reuse
What people ask about CGRP renewals
Anti-CGRP preventives are typically approved for a limited period and then re-evaluated. To renew coverage, payers generally want documentation that the treatment is working: most often a meaningful reduction in monthly migraine days from your pre-treatment baseline, plus evidence of adherence.